» Articles » PMID: 32836401

[Acute Viral Bronchiolitis and Wheezy Bronchitis in Children]

Overview
Specialty Pediatrics
Date 2020 Aug 25
PMID 32836401
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Acute viral bronchiolitis and wheezy bronchitis are very common disorders in infants and preschool children. They are caused by viruses, particularly by respiratory syncytial virus and rhinoviruses. Risk factors for severe disease include premature birth, tobacco smoke exposure and immune dysfunctions. Patient history and a physical examination are sufficient to establish a diagnosis; chest X-ray and laboratory investigations are not routinely necessary. For acute bronchiolitis, many treatment options have been suggested but only supportive measures, such as minimal handling, securing adequate oxygenation and hydration are generally recommended. Antibiotics, bronchodilators, corticosteroids und leukotriene receptor antagonists are not routinely recommended. Short-acting beta-2 agonists are the first choice for the treatment of wheezy bronchitis. Inhaled corticosteroids may be tried to control symptoms in children with frequently recurring and/or severe episodes of wheezy bronchitis. The development of bronchial asthma, however, cannot be prevented by any pharmacologic tretament.

Citing Articles

Respiratory Syncytial Virus-Associated Respiratory Diseases in Children and Adults.

Tenenbaum T, Liese J, Welte T, Rademacher J Dtsch Arztebl Int. 2024; 121(9):303-312.

PMID: 38652840 PMC: 11381200. DOI: 10.3238/arztebl.m2024.0060.


[Breathing disorders in children].

Blatt S, Schroth M Med Klin Intensivmed Notfmed. 2023; 118(8):638-645.

PMID: 37316572 DOI: 10.1007/s00063-023-01029-4.

References
1.
Brand P, Caudri D, Eber E, Gaillard E, Garcia-Marcos L, Hedlin G . Classification and pharmacological treatment of preschool wheezing: changes since 2008. Eur Respir J. 2014; 43(4):1172-7. DOI: 10.1183/09031936.00199913. View

2.
Hall C, Weinberg G, Blumkin A, Edwards K, Staat M, Schultz A . Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics. 2013; 132(2):e341-8. DOI: 10.1542/peds.2013-0303. View

3.
Jartti T, Smits H, Bonnelykke K, Bircan O, Elenius V, Konradsen J . Bronchiolitis needs a revisit: Distinguishing between virus entities and their treatments. Allergy. 2018; 74(1):40-52. PMC: 6587559. DOI: 10.1111/all.13624. View

4.
Gadomski A, Scribani M . Bronchodilators for bronchiolitis. Cochrane Database Syst Rev. 2014; (6):CD001266. PMC: 7055016. DOI: 10.1002/14651858.CD001266.pub4. View

5.
Kirolos A, Manti S, Blacow R, Tse G, Wilson T, Lister M . Corrigendum to: A Systematic Review of Clinical Practice Guidelines for the Diagnosis and Management of Bronchiolitis. J Infect Dis. 2020; 221(7):1204. DOI: 10.1093/infdis/jiz600. View